Lunit has announced a three-year supply agreement with Samsung Healthcare, focused on integrating its AI technology into Samsung’s premium X-ray devices to improve the accuracy and speed of chest screening.

Under the three-year contract, Lunit will supply Samsung with two AI-powered chest screening solutions: Lunit INSIGHT CXR, an AI-powered chest X-ray analysis solution, and Lunit INSIGHT CXR Triage, an FDA-cleared AI solution that identifies pre-specified critical findings.

The initial phase of this collaboration will target markets in the US, Canada and Europe, with future phases targeting the Middle East, South America and Southeast Asia.

The synergy between Lunit and Samsung will enable faster and more accurate chest screening, leading to timely intervention and improved patient outcomes,” said Brandon Suh, CEO of Lunit.

en_GBEnglish (UK)